期刊文献+

常见革兰阴性杆菌3年耐药性监测 被引量:21

Surveillance on antimicrobial resistance of commonly Gram-negative bacilli during three years
下载PDF
导出
摘要 目的了解我院2008—2010年常见革兰阴性杆菌分布情况及对各种常用抗菌药物的耐药性。方法采用纸片扩散法进行抗菌药物敏感实验,根据CLSI采用WHONET5.4软件进行数据分析。结果 3年分离革兰阴性菌共3789株,占77.1%,居前5位的为大肠埃希菌(873,23%),鲍曼不动杆菌(854,22.5%)、铜绿假单胞菌(657,17.3%)、克雷伯菌属(605,16%)及肠杆菌属(268,7%)。主要来源于痰液、分泌物、尿液及血液、脓液、胆汁等。大肠埃希菌、肺炎克雷伯菌对碳青霉烯类耐药率小于10%,2008年鲍曼不动杆菌对碳青霉烯类抗生素的耐药率为35%,2010年升高至68%,2008年对头孢哌酮/舒巴坦的敏感率为64%,2010年降至23.3%,铜绿假单胞菌对米诺环素、磺胺甲噁唑-甲氧苄啶的耐药率高于85.9%。结论医院感染以革兰阴性杆菌为主,临床应根据药敏结果合理使用抗菌药物。 Objective To investigate the distribution and antimicrobial resistance of commonly Gramnegative bacilli from the first affiliated hospital of Chongqing Medical University during 2008 to 2010. Methods Disk diffusion method was used to determine the antimicrobial susceptibility. And the WHONET 5.4 software was used to analyze the data based on the CLSI. Results From 2008 to 2010, a total of 3789 Gram-negative bacilli were isolated, accounting for 77.1% (3789/4916) during the 3 years, among which there were 873, 854, 657, 605, 268 strains of Escherichia coli, Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae and Enterobacter cloacae were isolated, respectively. They were mainly isolated from sputum, secretions, urine and blood, pus, bile, etc. The resistance rate of E.coli and Klebsiella spp to carbapenems was the lowest (〈 10%). The resistance rate ofA. baumannii to carbapenems was 35% in 2008, which increased to 68% in 2010. The susceptibility rate of A. baumannii to cefoperazone/sulbactam was 64% in 2008, which dropped to 23.3% in 2010. The resistance rate of P aeruginosa to minocycline and sulfamethoxazole-trimethoprim was higher than 85.9%. Conclusion The main hospital infections are Gram-negative bacilli, the selection of antibiotics should base on the drug susceptibility results.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2012年第10期783-788,共6页 Chinese Journal of Antibiotics
基金 中国Chinet细菌耐药监测组部分支助
关键词 革兰阴性杆菌 耐药性 抗菌药物 Gram negative bacilli Resistance Antimicrobial agent
  • 相关文献

参考文献9

二级参考文献15

  • 1王静,侯晓华.埃索美拉唑的临床应用进展[J].胃肠病学,2003,8(2):125-126. 被引量:39
  • 2Kahrilas PJ, Falk GW, Johnson DA, et al. Esomeprazole inproves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial [ J ]. Aliment Pharmacol Ther,2000,14 ( 10 ) : 1249 - 1258.
  • 3王卫卫,赵亚刚,孙大勇.埃索美拉唑为主三联治疗慢性肝炎合并十二指肠球部活动性溃疡疗效观察[J].中国医师杂志,2007,9(7):998-998. 被引量:3
  • 4Simon B,Muller P,Pascu O,et al.Intraoesophageal pH profiles and pharmacokinetics of pantoprazole and esomeprazole:acrossover study in patients with gastrooesophageal reflux disease[J].Eur J Gastroenterol Hepatol,2003,15(7):791-799.
  • 5Rohss K,Hasselgren G,Hedenstrom H.Effect of esomeprazole 40 mg vs omeprazole 40 mg on 24-hour intragastric pH in patients with symptoms of gastroesophageal reflux disease[J].Dig Dis Sci,2002,47 (5):954-958.
  • 6Kendall MJ.Review article:esomeprazole-the first proton pump inhibitor to be developed as an isomer[J].Aliment Pharmacol Ther,2003,17(suppl 1):1-4.
  • 7Castell DO,Kahrilas PJ,Richter JE,et al.Esomeprazole(40 mg) compared with lansoprazole(30 mg) in the treatment of erosive esophagitis[J].Am Gastroenterol,2002,97 (5):575-583.
  • 8van Zanen SV,Macchado S,Lee J.One-week triple therapy with esoprazole,clarithromycin and metronidazole provides effective eradication of Helicobacter pylori infection[J].Aliment Pharmacol Ther,2003,17(11):1381-1382.
  • 9袁志芳,张川,张澍田,高峰,阎雪燕,高辉,段卓洋.三联疗法根除十二指肠溃疡病患者Hp感染效果及影响因素分析[J].山东医药,2009,49(16):6-8. 被引量:35
  • 10任旭.反流性食管炎的内镜和病理学诊断及分级[J].世界华人消化杂志,2000,8(10):1127-1136. 被引量:32

共引文献218

同被引文献178

引证文献21

二级引证文献86

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部